FGEN Fibrogen Inc

FibroGen Inc is a biopharmaceutical company. It is engaged in the discovery, development and commercialization of novel therapeutics to treat serious unmet medical needs.

$10.59  -0.34 (-3.11%)
As of 06/30/2022 15:59:56 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  11/14/2014
Outstanding shares:  93,297,542
Average volume:  861,296
Market cap:   $1,019,742,134
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      BSDRYR8
Valuation   (See tab for details)
PE ratio:   -3.50
PB ratio:   6.23
PS ratio:   3.96
Return on equity:   -178.09%
Net income %:   -109.22%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy